AlphaMark Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $12K | Hold |
150
| – | – | 0.01% | 423 |
|
|
2024
Q3 | $14K | Hold |
150
| – | – | ﹤0.01% | 476 |
|
|
2024
Q2 | $12K | Hold |
150
| – | – | ﹤0.01% | 505 |
|
|
2024
Q1 | $13K | Buy |
150
+50
| +50% | +$4.27K | ﹤0.01% | 497 |
|
|
2023
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 551 |
|
|
2023
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 542 |
|
|
2023
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 424 |
|
|
2023
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 439 |
|
|
2022
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 402 |
|
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 449 |
|
|
2022
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 408 |
|
|
2022
Q1 | $11K | Hold |
100
| – | – | ﹤0.01% | 397 |
|
|
2021
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 396 |
|
|
2021
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 375 |
|
|
2021
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 384 |
|
|
2021
Q1 | $12K | Hold |
100
| – | – | ﹤0.01% | 374 |
|
|
2020
Q4 | $12K | Hold |
100
| – | – | ﹤0.01% | 352 |
|
|
2020
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 363 |
|
|
2020
Q2 | $9K | Sell |
100
-37
| -27% | -$3.55K | ﹤0.01% | 377 |
|
|
2020
Q1 | $12K | Buy |
137
+37
| +37% | +$3.94K | 0.01% | 285 |
|
|
2019
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 321 |
|
|
2019
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 319 |
|
|
2019
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 335 |
|
|
2019
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 334 |
|
|
2018
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 325 |
|
|
2018
Q3 | $10K | Sell |
100
-235
| -70% | -$21.7K | ﹤0.01% | 347 |
|
|
2018
Q2 | $29K | Buy |
335
+235
| +235% | +$19.6K | 0.01% | 264 |
|
|
2018
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 372 |
|
|
2017
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 374 |
|
|
2017
Q3 | $8K | Sell |
100
-25
| -20% | -$2.08K | ﹤0.01% | 363 |
|
|
2017
Q2 | $11K | Buy |
125
+25
| +25% | +$2.11K | ﹤0.01% | 330 |
|
|
2017
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 354 |
|
|
2016
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 344 |
|
|
2016
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 249 |
|
|
2016
Q2 | $9K | Hold |
100
| – | – | 0.01% | 242 |
|
|
2016
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 238 |
|
|
2015
Q4 | $8K | Buy |
+100
| New | +$7.53K | ﹤0.01% | 240 |
|
Other funds holding MDT
AlphaMark Advisors's MDT Position: Q4 2024 in Review
AlphaMark Advisors held its Medtronic (MDT) position steady in Q4 2024 at 150 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #423.
AlphaMark Advisors first reported a position in MDT in Q4 2015 and has held it in 37 quarters since. The position peaked at $29K in Q2 2018. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.
- AlphaMark Advisors held 150 shares of Medtronic worth $12K as of Q4 2024.
- AlphaMark Advisors left its Medtronic share count unchanged in Q4 2024.
- Medtronic made up 0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #423 holding.
- AlphaMark Advisors first reported a position in Medtronic in Q4 2015 and has held it in 37 quarters since.
- AlphaMark Advisors's Medtronic position peaked at $29K in Q2 2018.
- 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.